Table 15. Analysis of changes in CK2 gene expression in sarcoma.
Gene | p-value | Fold Change | Rank (Top %) | Dataset | #Samples | Reference |
---|---|---|---|---|---|---|
Dedifferentiated Liposarcoma | ||||||
CK2α’ | 2.49 10−4 | -1.599 | 11% | Barretina Sarcoma | 158 | [128] |
CK2β | 0.007 | -1.815 | 5% | Detwiller Sarcoma | 54 | [129] |
Fibrosarcoma | ||||||
CK2α | 7.85 10−4 | 1.975 | 7% | Detwiller Sarcoma | 54 | [129] |
CK2α’ | 0.009 | -1.464 | 11% | Detwiller Sarcoma | 54 | [129] |
Malignant fibrous histiocytoma (Pleomorphic Undifferentiated Sarcoma) | ||||||
CK2α’ | 0.011 | -1.534 | 14% | Detwiller Sarcoma | 54 | [129] |
Leiomyosarcoma | ||||||
CK2α’ | 0.002 | 1.392 | 1% | Quade Uterus | 24 | [130] |
1.49 10−4 | -2.153 | 2% | Detwiller Sarcoma | 54 | [129] | |
Myxofibrosarcoma | ||||||
CK2α’ | 0.001 | -1.448 | 19% | Barretina Sarcoma | 158 | [128] |
Pleomorphic Liposarcoma | ||||||
CK2α | 0.003 | 1.422 | 6% | Detwiller Sarcoma | 54 | [129] |
CK2α’ | 0.003 | -1.693 | 4% | Detwiller Sarcoma | 54 | [129] |
0.001 | -1.494 | 12% | Barretina Sarcoma | 158 | [128] | |
CK2β | 5.13 10−5 | 1.334 | 11% | Barretina Sarcoma | 158 | [128] |
Synovial Sarcoma | ||||||
CK2α | 1.28 10−4 | 1.801 | 5% | Detwiller Sarcoma | 54 | [129] |